Anti-IL-7 receptor antibodies
    2.
    发明授权
    Anti-IL-7 receptor antibodies 有权
    抗IL-7受体抗体

    公开(公告)号:US08298535B2

    公开(公告)日:2012-10-30

    申请号:US13033491

    申请日:2011-02-23

    IPC分类号: A61K39/395 C07K16/28 C12N5/12

    摘要: The present invention provides antagonizing antibodies that bind to interleukin-7 receptor (IL-7R). The invention further provides a method of obtaining such antibodies and antibody-encoding nucleic acids. The invention further relates to therapeutic methods for use of these antibodies and antigen-binding portions thereof for the treatment and/or prevention of type 2 diabetes and immunological disorders, including type 1 diabetes, multiple sclerosis, rheumatoid arthritis, graft-versus-host disease, and lupus.

    摘要翻译: 本发明提供了结合白细胞介素-7受体(IL-7R)的拮抗性抗体。 本发明还提供了获得这样的抗体和抗体编码核酸的方法。 本发明还涉及这些抗体及其抗原结合部分用于治疗和/或预防2型糖尿病和免疫学障碍(包括1型糖尿病,多发性硬化症,类风湿性关节炎,移植物抗宿主病)的治疗方法 ,和狼疮。